Pfizer to discontinue twice-daily version of weight loss pill

CFOTO | Future Publishing | Getty ImagesPfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high rates of adverse side...

Read more...

Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes

A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August 31, 2023.Victoria Klesty | ReutersNovo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and "potentially unsafe" drugs claiming to contain semaglutide,...

Read more...

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.Dado Ruvic | ReutersBiotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% Thursday, putting it on track...

Read more...

Cigna shares slide after report it could merge with Humana

The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023. BlooJoe Buglewicz | Bloomberg | Getty ImagesShares of Cigna slid on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants.Spokespeople for Cigna and Humana did...

Read more...

Mounjaro superior to Ozempic for weight loss, study says

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023.George Frey | ReutersThe blockbuster diabetes drug Mounjaro is more effective for weight loss than another highly popular treatment,...

Read more...

CDC expedites release of Sanofi, AstraZeneca drug amid shortage

A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children's clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | ReutersThe Centers for Disease Control and Prevention expedited the release of more than 77,000 additional doses of a new drug designed to protect infants from...

Read more...

Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly

CFOTO | Future Publishing | Getty ImagesAs its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer's experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the space's dominant players Eli Lilly...

Read more...

FDA approves Eli Lilly drug tirzepatide for weight loss

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023.George Frey | ReutersThe Food and Drug Administration on Wednesday approved Eli Lilly's blockbuster drug tirzepatide for weight loss,...

Read more...